Flexibility to help meet
your patients' needs1

Dosed

Quarterly or Monthly1

AJOVY® is the only licensed anti-CGRP treatment that offers the choice between quarterly and monthly dosing, with the option to switch between the two

CGRP, calcitonin gene-related peptide.

ADMINISTERED

AJOVY® may be self administered1

Patients may self-administer AJOVY® if instructed in subcutaneous self-injection technique by a healthcare professional

STUDIED

Alone and in combination1

In Phase III trials, more than 20% of enrolled patients were taking oral concomitant preventive medications

Suggestions to explore next

Continue to Adminstration page of AJOVY

Can be administered at home or in the clinic1

Administering ajovy®
Continue to Efficacy page of AJOVY

Significantly more migraine-free days with AJOVY® vs placebo1-3

Clinical trial data for AJOVY®

Better quality of life with AJOVY® vs placebo2,3

Quality of life data for ajovy®